| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2022 | MTD Mettler Toledo International Inc/ | Chu Wah-Hui63 | Director | Sell | 584 | $1,398.94 | $816,980.96 | -12.0% | +7.3% | -28.0% | |
| Nov 10, 2022 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 800 | $1,435.08 | $1,148,064.00 | -7.3% | +7.3% | -28.0% | |
| Nov 10, 2022 | BIO Bio-Rad Laboratories, Inc. | Ramalingam Ajit59 | SVP, Chief Accounting Officer | Sell | 379 | $421.87 | $160,050.61 | -77.1% | +9.8% | -28.9% | |
| Nov 10, 2022 | MTD Mettler Toledo International Inc/ | Aggersbjerg Peter54 | Head Of Divisions | Sell | 2,513 | $1,414.85 | $3,555,526.49 | -33.8% | +7.3% | -28.0% | |
| Nov 10, 2022 | BDSX Biodesix Inc | Siurek Ryan H64 | Chief Accounting Officer | Sell | 1,725 | $1.03 | $1,778.59 | -5.3% | +88.2% | +17.6% | |
| Nov 10, 2022 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 13,777 | $1.03 | $14,204.96 | -5.9% | +88.2% | +17.6% | |
| Nov 10, 2022 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 3,582 | $1.03 | $3,693.26 | -2.3% | +88.2% | +17.6% | |
| Nov 10, 2022 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 1,705 | $1.03 | $1,757.97 | -5.2% | +88.2% | +17.6% | |
| Nov 10, 2022 | BDSX Biodesix Inc | Georgantas Robert William III | Chief Scientific Officer | Sell | 1,776 | $1.03 | $1,831.16 | -3.2% | +88.2% | +17.6% | |
| Nov 10, 2022 | TTOO T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | Sell | 1,292 | $1.79 | $2,316.56 | -36.4% | - | - | |
| Nov 10, 2022 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 1,580 | $1.03 | $1,629.08 | -0.8% | +88.2% | +17.6% | |
| Nov 9, 2022 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 6,775 | $138.31 | $937,050.25 | -3.4% | +12.8% | -21.4% | |
| Nov 9, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 200,000 | $1.60 | $319,423.60 | - | -12.9% | -17.4% | |
| Nov 8, 2022 | MTD Mettler Toledo International Inc/ | Kelly Michael A46 | Director | Sell | 1,484 | $1,356.36 | $2,012,841.60 | -26.9% | +15.2% | -23.1% | |
| Nov 8, 2022 | MTD Mettler Toledo International Inc/ | Magloth Christian66 | Head Of Human Resources | Sell | 1,270 | $1,331.92 | $1,691,537.80 | -56.5% | +15.2% | -23.1% | |
| Nov 8, 2022 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 3,000 | $1,311.67 | $3,935,000.00 | -18.6% | +15.2% | -23.1% | |
| Nov 7, 2022 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,958 | $20.35 | $182,271.08 | -0.5% | +35.6% | -8.6% | |
| Nov 7, 2022 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 880 | $1,299.43 | $1,143,501.16 | -8.2% | +19.8% | -19.7% | |
| Nov 7, 2022 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 18,100 | $490.83 | $8,884,007.62 | -0.6% | +17.1% | -6.6% | |
| Nov 4, 2022 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 534 | $216.36 | $115,536.24 | -2.6% | +18.0% | -17.4% | |
| Nov 4, 2022 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 1,023 | $25.00 | $25,575.00 | -1.5% | +14.4% | +0.3% | |
| Nov 3, 2022 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 8,200 | $487.45 | $3,997,056.04 | -0.6% | +20.7% | -6.6% | |
| Nov 3, 2022 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 11,800 | $500.06 | $5,900,693.80 | -0.3% | +20.7% | -6.6% | |
| Nov 2, 2022 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 6,775 | $140.61 | $952,632.75 | -3.4% | +12.4% | -22.8% | |
| Nov 1, 2022 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 3,600 | $139.50 | $502,200.00 | -7.7% | +7.7% | -27.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.